#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Basal cell naevus syndrome Aplastic anaemia Chronic granulomatous disease Lennox-Gastaut syndrome Mucopolysaccharidosis II Diffuse large B-cell lymphoma refractory Leukoencephalopathy Neuropathy peripheral Synovitis Deafness bilateral Glomerulonephritis rapidly progressive Plasma cell myeloma refractory Congenital myopathy Hereditary hypophosphataemic rickets Netherton's syndrome More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Trials in Disease Systemic sclerosis pulmonary Factor VIII deficiency – Treatment Pemphigoid – Life with Disease Marginal zone lymphoma refractory – Trials in Disease Epidermolysis bullosa – Diagnostics Von Willebrand’s disease – Diagnostics Angiosarcoma non-metastatic Soft tissue sarcoma – Diagnostics Basal cell naevus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vudalimab PIPOTIAZINE Nelivaptan Sonidegib LY3848575 Ferric Derisomaltose Oxytocin Livmoniplimab Thiocolchicoside ZILUCOPLAN Eptinezumab Calcifediol Epcoritamab Dexamethasone Isonicotinate IG-TREGS Azd0305 Erlotinib Carbetocin Minocycline Levothyroxine More therapies…

    Learn about Your Condition

    Erythema Brain neoplasm malignant Hepatitis alcoholic Hepatic angiosarcoma Atrial fibrillation Colorectal adenocarcinoma Primary hyperthyroidism Lung adenocarcinoma Soft tissue sarcoma Gastrooesophageal cancer Medulloblastoma Encephalitis Japanese B Small fibre neuropathy Vomiting Diabetic retinopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 154, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Crizotinib
    • Entrectinib
    Croatia France Germany Greece Italy The Netherlands +4

  • Study on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Favezelimab
    • Quavonlimab
    • Tretinoin
    France Greece Hungary Italy Poland Spain

  • Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

    Not recruiting

    3 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Ibrutinib
    Austria Belgium Czechia France Greece Hungary +5

  • Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Cilastatin
    • Imipenem Anhydrate
    • Tebipenem Pivoxil Hydrobromide
    Bulgaria Croatia Estonia Greece Hungary Latvia +3

  • Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Bemarituzumab
    • Folinic Acid
    • Fluorouracil
    Belgium Bulgaria Czechia Denmark Estonia France +12

  • Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

    Not recruiting

    3 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Austria Belgium Czechia France Germany Greece +6

  • Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Czechia Denmark Greece Hungary Italy Poland +1

  • Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • Sebetralstat
    Austria Bulgaria France Germany Greece Hungary +7

  • Long-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bexotegrast
    Belgium Czechia Denmark France Germany Greece +5
Previous Page
1 … 25 26 27 28 29 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!